CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.

Handel Alimera Sciences, Inc. - ALIM CFD

2.57
1.98%
  • Opsummering
  • Historisk Data
  • Begivenheder
  • Resultatopgørelse
  • Saldo
  • Cash flow
  • Ejerskab
Handelsbetingelser
Spænd 0.28
Long position, gebyr natten over

Long position overnight fee


Margin. Your investment $1,000.00
Gebyr for natten over -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Gå til platform
-0.025457%
Short position, gebyr natten over

Short position overnight fee


Margin. Your investment $1,000.00
Gebyr for natten over 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Gå til platform
0.003235%
Gebyr natten over, tid 21:00 (UTC)
Min. handlet mængde 1
Valuta USD
Margen 20%
Aktiebørs United States of America
Kommission på handel 0%

*Information provided by Capital.com

Nøglestatistikker
Tidligere luk* 2.52
Åben* 2.52
1-Års Ændring* -54.84%
Dagens Spænd* 2.5 - 2.66
52-Ugers Spænd 1.30-7.92
Gennemsnitlig Volumen (10 dage) 3.75M
Gennemsnitlig Volumen (3 måneder) 12.93M
Market Cap 19.33M
P/E-forhold -100.00K
Udestående aktier 7.40M
Omsætning 55.78M
EPS -2.44
Dividend (Udbytte %) N/A
Beta 1.39
Næste indtjeningsopgørelse Jul 25, 2023

Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Luk Change Change (%) Åben High Low
Jun 2, 2023 2.57 0.06 2.39% 2.51 2.66 2.50
Jun 1, 2023 2.52 -0.08 -3.08% 2.60 2.60 2.51
May 31, 2023 2.67 0.19 7.66% 2.48 2.67 2.48
May 30, 2023 2.52 0.05 2.02% 2.47 2.55 2.47
May 26, 2023 2.49 0.08 3.32% 2.41 2.52 2.35
May 25, 2023 2.48 -0.02 -0.80% 2.50 2.51 2.37
May 24, 2023 2.41 0.23 10.55% 2.18 2.42 2.14
May 23, 2023 2.32 -0.19 -7.57% 2.51 2.55 2.21
May 22, 2023 2.45 0.28 12.90% 2.17 2.72 2.15
May 19, 2023 2.23 0.12 5.69% 2.11 2.30 2.02
May 18, 2023 2.34 -0.26 -10.00% 2.60 3.05 2.26
May 17, 2023 1.93 0.11 6.04% 1.82 1.94 1.78
May 16, 2023 1.79 0.21 13.29% 1.58 1.92 1.58
May 15, 2023 1.57 -0.03 -1.88% 1.60 1.68 1.56
May 12, 2023 1.56 -0.05 -3.11% 1.61 1.64 1.55
May 11, 2023 1.57 0.02 1.29% 1.55 1.64 1.48
May 10, 2023 1.52 -0.11 -6.75% 1.63 1.85 1.51
May 9, 2023 1.63 -0.14 -7.91% 1.77 1.77 1.63
May 8, 2023 1.73 -0.06 -3.35% 1.79 1.80 1.73
May 5, 2023 1.83 -0.05 -2.66% 1.88 2.04 1.76

Alimera Sciences, Inc. Events

Tid (UTC) (UTC) Land Begivenhed
Wednesday, July 12, 2023

Tid (UTC) (UTC)

13:30

Land

US

Begivenhed

Alimera Sciences Inc Annual Shareholders Meeting
Alimera Sciences Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Tuesday, July 25, 2023

Tid (UTC) (UTC)

12:30

Land

US

Begivenhed

Q2 2023 Alimera Sciences Inc Earnings Release
Q2 2023 Alimera Sciences Inc Earnings Release

Forecast

-

Previous

-
Monday, November 13, 2023

Tid (UTC) (UTC)

13:30

Land

US

Begivenhed

Q3 2023 Alimera Sciences Inc Earnings Release
Q3 2023 Alimera Sciences Inc Earnings Release

Forecast

-

Previous

-
Se alle begivenheder
  • Årlig
  • Pr kvartal
2022 2021 2020 2019 2018
Total omsætning 54.129 59.029 50.82 53.943 46.599
Omsætning 54.129 59.029 50.82 53.943 46.599
Kost af omsætning, Total 7.977 7.03 6.941 6.626 4.308
Bruttofortjeneste 46.152 51.999 43.879 47.317 42.291
Totale Driftsudgifter 65.769 57.438 51.321 59.217 58.035
Salgs/Generelle/Admin. Udgifter, Total 38.858 35.843 32.036 38.958 38.042
Forskning & Udvikling 16.228 13.778 9.668 10.992 11.274
Depreciation / Amortization 2.706 2.579 2.676 2.641 2.645
Usædvanlig Udgift (Indkomst) 0 -1.792 0 1.766
Driftsindtægter -11.64 1.591 -0.501 -5.274 -11.436
Renteindkomst (Udgift), Netto Ikke-Drift -5.789 -4.997 -4.906 -4.953 -4.84
Netto Indkomst Før Skat -18.079 -3.934 -5.407 -10.227 -16.276
Netto Indkomst Efter Skat -18.107 -4.372 -5.339 -10.443 -16.382
Netto Indkomst Før Ekstra Ting -18.107 -4.372 -5.339 -10.443 -16.382
Netto Indkomst -18.107 -4.372 -5.339 -10.443 -16.382
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -18.107 -4.372 -5.339 -10.443 21.948
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -18.107 -4.372 -5.339 -10.443 21.948
Fortyndet Netto Indkomst -18.107 -4.372 -5.339 -10.443 21.948
Fortyndet Vægtet Gennemsnit Aktier 6.99685 6.59524 5.11766 4.7702 5.91587
Fortyndet EPS Uden Ekstraordinære Ting -2.58788 -0.6629 -1.04325 -2.18921 3.71002
Fortyndet Normaliseret EPS -2.58788 -0.83951 -1.04325 -2.18921 3.90406
Other Operating Expenses, Total
Totale Ekstraordinære Ting 0 0
Total Adjustments to Net Income 0 38.33
Andre, Netto -0.65 -0.528
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total omsætning 13.546 14.029 13.598 14.604 11.898
Omsætning 13.546 14.029 13.598 14.604 11.898
Kost af omsætning, Total 2.028 2.125 2.006 2.166 1.68
Bruttofortjeneste 11.518 11.904 11.592 12.438 10.218
Totale Driftsudgifter 16.848 16.137 17.009 16.578 16.045
Salgs/Generelle/Admin. Udgifter, Total 9.975 9.099 9.856 9.81 10.093
Forskning & Udvikling 4.164 4.23 4.483 3.932 3.583
Depreciation / Amortization 0.681 0.683 0.664 0.67 0.689
Driftsindtægter -3.302 -2.108 -3.411 -1.974 -4.147
Renteindkomst (Udgift), Netto Ikke-Drift -1.68 -1.621 -1.567 -1.345 -1.256
Netto Indkomst Før Skat -4.968 -3.781 -5.245 -3.098 -5.955
Netto Indkomst Efter Skat -4.968 -3.78 -5.257 -3.115 -5.955
Netto Indkomst Før Ekstra Ting -4.968 -3.78 -5.257 -3.115 -5.955
Netto Indkomst -4.968 -3.78 -5.257 -3.115 -5.955
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -4.982 -3.78 -5.257 -3.115 -5.955
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -4.982 -3.78 -5.257 -3.115 -5.955
Fortyndet Netto Indkomst -4.982 -3.78 -5.257 -3.115 -5.955
Fortyndet Vægtet Gennemsnit Aktier 7.03223 7.00032 6.99658 6.99971 6.99074
Fortyndet EPS Uden Ekstraordinære Ting -0.70845 -0.53998 -0.75137 -0.44502 -0.85184
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Fortyndet Normaliseret EPS -0.70845 -0.53998 -0.75137 -0.44502 -0.85184
Usædvanlig Udgift (Indkomst) 0 0 0
Andre, Netto 0.014 -0.052 -0.267 0.221 -0.552
Total Adjustments to Net Income -0.014
  • Årlig
  • Pr kvartal
2022 2021 2020 2019 2018
Totale Nuværende Aktiver 29.413 42.16 34.906 32.745 34.848
Likvider og Kortsigtede Investeringer 5.274 16.51 11.208 9.426 13.043
Likvider & Lignende 5.274 16.51 11.208 9.426 13.043
Totale Tilgodehavender, Netto 19.612 19.128 17.2 19.331 17.259
Accounts Receivable - Trade, Net 19.612 19.128 17.2 19.331 17.259
Total Inventory 1.605 2.679 2.746 1.39 2.405
Prepaid Expenses 2.892 3.809 3.718 2.565 2.109
Other Current Assets, Total 0.03 0.034 0.034 0.033 0.032
Total Assets 42.602 58.52 50.855 50.309 54.108
Property/Plant/Equipment, Total - Net 3.92 4.493 2.358 2.047 1.355
Property/Plant/Equipment, Total - Gross 7.981 7.923 6.305 5.858 4.967
Accumulated Depreciation, Total -4.061 -3.43 -3.947 -3.881 -3.612
Intangibles, Net 8.957 10.897 12.838 14.783 16.723
Other Long Term Assets, Total 0.129 0.137 0.753 0.734 1.182
Total Current Liabilities 39.732 12.592 12.348 12.048 10.234
Accounts Payable 10.088 8.706 7.461 7.077 6.355
Accrued Expenses 3.998 3.617 3.197 4.716 3.643
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 25.646 0.269 1.69 0.255 0.236
Other Current Liabilities, Total
Total Liabilities 63.41 61.125 58.833 54.754 51.386
Total Long Term Debt 18.683 43.08 42.922 38.752 38.178
Long Term Debt 18.683 43.08 42.408 38.658 37.873
Capital Lease Obligations 0.514 0.094 0.305
Other Liabilities, Total 4.995 5.453 3.563 3.954 2.974
Total Equity -20.808 -2.605 -7.978 -4.445 2.722
Preferred Stock - Non Redeemable, Net 19.227 19.227 19.227 30.344 30.344
Common Stock 0.07 0.069 0.057 0.05 0.701
Additional Paid-In Capital 378.238 377.229 365.83 350.117 346.108
Retained Earnings (Accumulated Deficit) -415.388 -397.281 -392.539 -383.863 -373.42
Other Equity, Total -2.955 -1.849 -0.553 -1.093 -1.011
Total Liabilities & Shareholders’ Equity 42.602 58.52 50.855 50.309 54.108
Total Common Shares Outstanding 6.99551 6.93515 5.71937 4.96595 4.67193
Total Preferred Shares Outstanding 0.6 0.6 0.6 0.61015 0.61015
Long Term Investments 0.183 0.833
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Totale Nuværende Aktiver 35.675 29.413 29.76 33.073 34.753
Likvider og Kortsigtede Investeringer 13.086 5.274 5.514 7.859 9.946
Likvider & Lignende 13.086 5.274 5.514 7.859 9.946
Totale Tilgodehavender, Netto 18.433 19.612 19.142 20.319 18.776
Accounts Receivable - Trade, Net 18.433 19.612 19.142 20.319 18.776
Total Inventory 1.215 1.605 1.786 1.656 2.452
Prepaid Expenses 2.91 2.892 3.29 3.208 3.546
Other Current Assets, Total 0.031 0.03 0.028 0.031 0.033
Total Assets 48.239 42.602 43.429 47.574 49.931
Property/Plant/Equipment, Total - Net 3.757 3.92 3.87 3.938 4.343
Intangibles, Net 8.479 8.957 9.446 9.935 10.419
Other Long Term Assets, Total 0.131 0.129 0.118 0.126 0.134
Total Current Liabilities 14.173 39.732 34.01 25.431 17.006
Accounts Payable 9.669 10.088 8.706 7.614 6.604
Accrued Expenses 4.241 3.998 3.661 3.316 3.046
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.263 25.646 21.643 14.501 7.356
Total Liabilities 67.155 63.41 61.507 59.909 58.534
Total Long Term Debt 44.312 18.683 22.492 29.297 36.245
Long Term Debt 44.152 18.683 22.492 29.297 36.245
Capital Lease Obligations 0.16
Other Liabilities, Total 8.67 4.995 5.005 5.181 5.283
Total Equity -18.916 -20.808 -18.078 -12.335 -8.603
Preferred Stock - Non Redeemable, Net 7.728 19.227 19.227 19.227 19.227
Common Stock 0.074 0.07 0.07 0.07 0.07
Additional Paid-In Capital 378.146 378.238 378.005 377.847 377.541
Retained Earnings (Accumulated Deficit) -402.081 -415.388 -411.608 -406.351 -403.236
Other Equity, Total -2.783 -2.955 -3.772 -3.128 -2.205
Total Liabilities & Shareholders’ Equity 48.239 42.602 43.429 47.574 49.931
Total Common Shares Outstanding 7.39159 6.99551 6.99802 6.99546 6.99265
Total Preferred Shares Outstanding 0.012 0.6 0.6 0.6 0.6
Long Term Investments 0.197 0.183 0.235 0.502 0.282
Other Current Liabilities, Total
  • Årlig
  • Pr kvartal
2022 2021 2020 2019 2018
Netto indkomst/Startlinje -18.107 -4.372 -5.339 -10.443 -16.382
Likvider Fra Driftsaktiviteter -9.975 -3.224 -2.193 -4.152 -11.553
Likvider Fra Driftsaktiviteter 2.706 2.579 2.676 2.641 2.645
Deferred Taxes 0.116 0.61 0.031 0.454 -0.653
Ikke-Likvide Ting 2.621 -0.692 1.829 3.377 7.084
Cash Taxes Paid 0.232 0.112 0.11 0.239 0.239
Likvid Rente Betalt 4.489 4.302 4.556 4.419 3.571
Ændringer i Driftskapital 2.689 -1.349 -1.39 -0.181 -4.247
Likvider fra Investeringsaktiviteter -0.255 -0.621 -0.62 -0.174 -0.175
Kapitaludgifter -0.255 -0.621 -0.62 -0.174 -0.175
Likvider fra Financieringsaktiviteter -0.302 9.823 3.882 0.869 0.95
Financiering af Cash-Flow-Ting -0.113 0 -0.019 -2.227 -3.808
Udstedelse (Pensionering) af Aktier, Netto 0.1 10.044 0.049 0.902 0.085
Udstedelse (Pensionering) af Gæld, Netto -0.289 -0.221 3.852 2.194 4.673
Udenlandsk Børs Effekter -0.708 -0.676 0.714 -0.159 -0.248
Netto Ændring i Likviditet -11.24 5.302 1.783 -3.616 -11.026
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -4.968 -18.107 -14.327 -9.07 -5.955
Cash From Operating Activities -2.209 -9.975 -9.724 -7.811 -6.213
Cash From Operating Activities 0.681 2.706 2.023 1.359 0.689
Non-Cash Items 0.507 2.621 2.095 1.318 1.027
Cash Taxes Paid 0 0.232 0.224 0.182 0.018
Cash Interest Paid 1.354 4.489 3.253 2.145 1.061
Changes in Working Capital 1.571 2.689 0.485 -1.418 -1.974
Cash From Investing Activities -0.009 -0.255 -0.171 -0.041 -0.149
Capital Expenditures -0.009 -0.255 -0.171 -0.041 -0.149
Cash From Financing Activities 9.998 -0.302 -0.109 -0.164 -0.062
Financing Cash Flow Items -3.123 -0.113
Issuance (Retirement) of Debt, Net 2.373 -0.289 -0.164 -0.204 -0.062
Foreign Exchange Effects 0.033 -0.708 -0.998 -0.638 -0.141
Net Change in Cash 7.813 -11.24 -11.002 -8.654 -6.565
Issuance (Retirement) of Stock, Net 10.748 0.1 0.055 0.04
Deferred Taxes 0.116
Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
Velan Capital Investment Management LP Investment Advisor/Hedge Fund 22.4131 1659654 1401901 2023-05-17 MED
Ocumension Therapeutics Corporation 15.4621 1144945 0 2023-04-24 LOW
Morgan Stanley & Co. LLC Research Firm 8.9243 660832 0 2023-03-31 MED
Caligan Partners, LP Hedge Fund 6.4657 478777 0 2023-05-17 MED
Eiswirth (Richard S Jr) Individual Investor 4.3555 322518 500 2023-04-24 LOW
HOOPP Investment Management Pension Fund 3.3762 250000 0 2023-03-31 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.0071 148624 0 2023-03-31 LOW
Ashman Philip Individual Investor 1.8004 133315 0 2023-04-24 MED
Holland (David R) Individual Investor 1.4704 108880 500 2023-04-24 LOW
Renaissance Technologies LLC Hedge Fund 1.3693 101394 -1100 2023-03-31 HIGH
Skibsted (Russell L) Individual Investor 1.0196 75500 58000 2023-03-26 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5167 38262 0 2023-03-31 LOW
Jones (John Philip) Individual Investor 0.4347 32186 372 2022-10-31
Millennium Management LLC Hedge Fund 0.3884 28762 16799 2023-03-31 HIGH
Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.2639 19542 0 2023-03-31 MED
Bridgeway Capital Management, LLC Investment Advisor 0.2471 18300 0 2023-03-31 LOW
Perritt Capital Management, Inc. Investment Advisor 0.2431 18000 0 2023-03-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.175 12962 438 2023-03-31 LOW
J.P. Morgan Securities LLC Research Firm 0.14 10364 9838 2023-03-31 MED
Snisarenko (John) Individual Investor 0.135 10000 0 2023-04-24 LOW

Hvorfor vælge Capital.com? Vores tal taler for sig selv.

Capital.com Group

535K+

Handlende

87K+

Månedlkige, aktive klienter

$113M+

Månedlig investeringsvolumen

$64M+

Hævet hver måned

Handelslommeregner

Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).

Handelskurtage
0
  • 1:1
Gearing
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben

Luk

Short Long

Alimera Sciences, Inc. Company profile

Om Alimera Sciences, Inc.

Alimera Sciences, Inc. er en lægemiddelvirksomhed. Virksomheden beskæftiger sig med markedsføring og udvikling af receptpligtige oftalmiske lægemidler. Selskabet fokuserer på sygdomme, der påvirker bagsiden af øjet eller nethinden. Selskabets kommercielle produkt, ILUVIEN, er et intravitrealt implantat, som behandler patienter ved at afgive en kontinuerlig mikrodosis af det ikke-proprietære kortikosteroid fluocinolonacetonid (FAc) i øjet i op til 36 måneder. Virksomheden er engageret i udvikling til behandling af diabetisk makulaødem (DME). DME er en sygdom i nethinden, der rammer personer med diabetes og kan føre til alvorligt synstab og blindhed. ILUVIEN kan også bruges til at forebygge tilbagefald ved tilbagevendende ikke-infektiøs uveitis, der påvirker det bageste segment af øjet (NIU-PS). Virksomheden markedsfører ILUVIEN direkte i USA, Tyskland, Det Forenede Kongerige, Portugal og Irland.

Industry: Biopharmaceuticals

Ste 290
6120 Windward Parkway
ALPHARETTA
GEORGIA 30005
US

Resultatopgørelse

  • Annual
  • Quarterly

Folk ser også

Gold

1,948.36 Price
-1.480% 1D Chg, %
Long position, gebyr natten over -0.0185%
Short position, gebyr natten over 0.0103%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.30

XRP/USD

0.52 Price
-1.380% 1D Chg, %
Long position, gebyr natten over -0.0753%
Short position, gebyr natten over 0.0069%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.00394

US100

14,557.80 Price
+0.640% 1D Chg, %
Long position, gebyr natten over -0.0255%
Short position, gebyr natten over 0.0032%
Gebyr natten over, tid 21:00 (UTC)
Spænd 3.0

BTC/USD

27,068.35 Price
-0.530% 1D Chg, %
Long position, gebyr natten over -0.0616%
Short position, gebyr natten over 0.0137%
Gebyr natten over, tid 21:00 (UTC)
Spænd 60.00

Leder du stadig efter en mægler, du kan stole på?

Deltag sammen med 535.000+ handlende over hele verden, der valgte at handle hos Capital.com

1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel